Cargando…
Nomogram predicts survival benefit for non- metastatic esophageal cancer patients who underwent preoperative radiotherapy
BACKGROUND: A prognostic model to predict the individual disease-specific survival (DSS) rates of non-metastatic esophageal cancer (nMEC) patients after preoperative radiotherapy (pRT) has not been established. In the current study, we aimed to establish a survival nomogram for nMEC patients after p...
Autores principales: | Xie, Kenan, Liu, Song, Liu, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152601/ https://www.ncbi.nlm.nih.gov/pubmed/30271214 http://dx.doi.org/10.2147/CMAR.S165168 |
Ejemplares similares
-
Nomogram predicts survival benefit from preoperative radiotherapy for non-metastatic breast cancer: A SEER-based study
por: Liu, Jianjun, et al.
Publicado: (2017) -
High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy
por: Wang, Chunyu, et al.
Publicado: (2015) -
Survival benefit of radiotherapy in metastatic esophageal cancer: a population-based study
por: Li, Xiangpan, et al.
Publicado: (2019) -
Dynamic Nomogram for Predicting Long-Term Survival in Terms of Preoperative and Postoperative Radiotherapy Benefits for Advanced Gastric Cancer
por: Li, Xinghui, et al.
Publicado: (2023) -
Genetic variant of ADH1C for predicting survival in esophageal squamous cell cancer patients who underwent postoperative radiotherapy
por: Xu, Xin, et al.
Publicado: (2022)